p-cyanocyclohexanecarboxylic acid | 4848-16-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: p-cyanocyclohexanecarboxylic acid
• 英文别名: 4-cyano-cyclohexane carboxylic acid；4-cyanocyclohexane-1-carboxylic acid
• CAS: 4848-16-2
• 化学式: C₈H₁₁NO₂
• 分子量: 153.181
• InChiKey: KJZWYCAIEUYAIW-UHFFFAOYSA-N

物化性质

• 熔点：
  151-152 °C
• 沸点：
  348.1±35.0 °C(Predicted)
• 密度：
  1.15±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  61.1
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  p-cyanocyclohexanecarboxylic acid 生成 4-Cyanocyclohexane-1-carboxamide
  参考文献：
  名称：

  OTSUBO, KADZUMASA

  摘要：

  DOI：
• 作为产物：
  描述：

  环己烷-1,4-二甲腈 生成 p-cyanocyclohexanecarboxylic acid
  参考文献：
  名称：

  TANI, JOSIKI;YAMAMOTO, KEHJDZO

  摘要：

  DOI：

文献信息

• [EN] NOVEL TRICYCLIC COMPOUNDS AS INHIBITORS OF MUTANT IDH ENZYMES<br/>[FR] COMPOSÉS TRICYCLIQUES INNOVANTS SERVANT D'INHIBITEURS D'ENZYMES IDH MUTANTES
  申请人：MERCK SHARP & DOHME

  公开号：WO2016089797A1

  公开（公告）日：2016-06-09

  The present invention is directed to tricyclic compounds of formula (I) which are inhibitors of one or more mutant IDH enzymes: (I). The present invention is also directed to uses of the tricyclic compounds described herein in the potential treatment or prevention of cancers in which one or more mutant IDH enzymes are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such cancers.

  本发明涉及式(I)的三环化合物，该化合物是野生型异柠檬酸脱氢酶（IDH）抑制剂：(I)。本发明还涉及将此处描述的三环化合物用于潜在治疗或预防涉及一个或多个突变IDH酶的癌症。本发明还涉及包含这些化合物的组合物。本发明还涉及将这些组合物用于潜在预防或治疗此类癌症。
• PYRROLIDINE DERIVATIVES
  申请人：Knust Henner

  公开号：US20110144081A1

  公开（公告）日：2011-06-16

  The present invention relates to compounds of formula wherein R 1 , R 2 , R 3 , R 4 , Z, and n are as defined herein or to a pharmaceutically active salt thereof. Compounds of the invention are high potential NK-3 receptor antagonists for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD).

  本发明涉及以下式中的化合物，其中R1、R2、R3、R4、Z和n如本文所定义，或其药用活性盐。本发明的化合物是治疗抑郁症、疼痛、精神病、帕金森病、精神分裂症、焦虑症和注意力缺陷多动障碍（ADHD）的高潜力NK-3受体拮抗剂。
• [EN] PHOTOALIGNING MATERIALS<br/>[FR] MATÉRIAUX DE PHOTOALIGNEMENT
  申请人：ROLIC AG

  公开号：WO2013050121A1

  公开（公告）日：2013-04-11

  The present invention relates to polymer, homo- or copolymer or oligomer for the photoalignment of liquid crystals, especially for the planar orientation of liquid crystals, comprising a main chain and a side chain, wherein the side chain and/or main chain comprises a polar group, compositions thereof, and its use for optical and electro optical devices, especially liquid crystal devices (LCDs).

  本发明涉及用于液晶的光调向的聚合物、同聚物或寡聚物，特别用于液晶的平面取向，包括主链和侧链，其中侧链和/或主链包含极性基团，以及其组合物，以及其在光学和电光设备中的应用，特别是液晶设备（LCD）。
• [EN] SUBSTITUTED PYRROLIDINES AS FACTOR XIA INHIBITORS FOR THE TREATMENT THROMBOEMBOLIC DISEASES<br/>[FR] PYRROLIDINES SUBSTITUÉES COMME INHIBITEURS DU FACTEUR XIA POUR LE TRAITEMENT DE MALADIES THROMBOEMBOLIQUES
  申请人：ONO PHARMACEUTICAL CO

  公开号：WO2013174937A1

  公开（公告）日：2013-11-28

  The present invention provides compounds of the general formula (I), their salts and N- oxides, and solvates and prodrugs thereof (wherein the substituents are as defined in the description). The compounds of the general formula (I) are inhibitors of factor XIa, and are useful in the prevention of and/or therapy for thromboembolic diseases.

  本发明提供了一般式(I)的化合物，以及它们的盐和N-氧化物、溶剂合物和前药（其中取代基如描述中定义）。一般式(I)的化合物是XIa因子的抑制剂，对预防和/或治疗血栓栓塞性疾病有用。
• SUBSTITUTED PYRROLIDINES AS FACTOR XIA INHIBITORS FOR THE TREATMENT THROMBOEMBOLIC DISEASES
  申请人：Imagawa Akira

  公开号：US20150152048A1

  公开（公告）日：2015-06-04

  The present invention provides compounds of the general formula (I), their salts and N-oxides, and solvates and prodrugs thereof (wherein the substituents are as defined in the description). The compounds of the general formula (I) are inhibitors of factor XIa, and are useful in the prevention of and/or therapy for thromboembolic diseases.

  本发明提供了一般式(I)的化合物，及其盐和N-氧化物，以及它们的溶剂合物和前药（其中取代基如描述中定义）。一般式(I)的化合物是因子XIa的抑制剂，并且在预防和/或治疗血栓栓塞疾病方面具有用途。